Marshall Wace, LLP ADVERUM BIOTECHN Transaction History
Marshall Wace, LLP
- $77.3 Billion
- Q3 2024
Number of Shares
42,897
Previous 204,619
79.04%
Holding current value
$0
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%